Business Description
Atara Biotherapeutics Inc
NAICS : 325412
SIC : 2836
ISIN : US0465131078
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.89 | |||||
Equity-to-Asset | -0.6 | |||||
Debt-to-Equity | -0.58 | |||||
Debt-to-EBITDA | -0.22 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | -22.11 | |||||
Beneish M-Score | -16.93 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 14.8 | |||||
3-Year EPS without NRI Growth Rate | 14.3 | |||||
3-Year FCF Growth Rate | 9.9 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.17 | |||||
9-Day RSI | 51.89 | |||||
14-Day RSI | 50.53 | |||||
6-1 Month Momentum % | -49.28 | |||||
12-1 Month Momentum % | -76.17 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.72 | |||||
Quick Ratio | 0.65 | |||||
Cash Ratio | 0.36 | |||||
Days Inventory | 255.36 | |||||
Days Sales Outstanding | 642 | |||||
Days Payable | 215.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.5 | |||||
Shareholder Yield % | -10.06 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -3.65 | |||||
Operating Margin % | -3219.48 | |||||
Net Margin % | -3220.88 | |||||
FCF Margin % | -2271.05 | |||||
ROE % | -2818.48 | |||||
ROA % | -107.93 | |||||
ROIC % | -221.26 | |||||
ROC (Joel Greenblatt) % | -403.67 | |||||
ROCE % | -161.87 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 8.75 | |||||
EV-to-EBIT | -0.33 | |||||
EV-to-EBITDA | -0.34 | |||||
EV-to-Revenue | 10.46 | |||||
EV-to-Forward-Revenue | 2.24 | |||||
EV-to-FCF | -0.46 | |||||
Earnings Yield (Greenblatt) % | -303.03 | |||||
FCF Yield % | -232.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Atara Biotherapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 7.93 | ||
EPS (TTM) (€) | -2.432 | ||
Beta | -0.16 | ||
Volatility % | 101.6 | ||
14-Day RSI | 50.53 | ||
14-Day ATR (€) | 0.034562 | ||
20-Day SMA (€) | 0.64978 | ||
12-1 Month Momentum % | -76.17 | ||
52-Week Range (€) | 0.2003 - 2.692 | ||
Shares Outstanding (Mil) | 119.36 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Atara Biotherapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Atara Biotherapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Atara Biotherapeutics Inc Frequently Asked Questions
What is Atara Biotherapeutics Inc(FRA:AT2)'s stock price today?
When is next earnings date of Atara Biotherapeutics Inc(FRA:AT2)?
Does Atara Biotherapeutics Inc(FRA:AT2) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |